Oncology Generics Medicines

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")

Source
OJEU
Type
Framework (Supply)
Duration
2 year (est.)
Value
£29M
Sector
HEALTH
Published
10 Feb 2021
Delivery
To 10 Feb 2023 (est.)
Deadline
n/a

Concepts

Location

All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014

Geochart for 2 buyers and 69 suppliers

2 buyers

28 suppliers

Description

This framework agreement is for the supply of Oncology Generic medicines to NHS Scotland. The goods have been separated into thirty-nine (39) categories, each of which is identified as a ‘Lot’. Full details of each lot is contained in section II.2) of this notice.

Lot Division

1 Bendamustine Powder For Solution For Infusion

Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
2 Capecitabine Tablets

Supply of Capecitabine Tablets to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.
3 Carboplatin Injection

Supply of Carboplatin Injections to NHS Scotland The authority has awarded all presentations within this lot to a single supplier.
4 Cisplatin Injection

Supply of Cisplatin Injections to NHS Scotland The authority has awarded all presentations within this lot to a single supplier.
5 Cyclophosphamide Injection, Powder For Reconstitution

Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
6 Cytarabine Injections

Supply of Cytarabine Injections to NHS Scotland The authority has awarded all presentations within this lot to a single supplier.
7 Dacarbazine Injections

Supply of Dacarbazine Injections to NHS Scotland The authority has awarded all presentations within this lot to a single supplier.
8 Disodium Folinate Injection

Supply of Disodium Folinate Injections to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
9 Docetaxel Concentrate For Solution For Infusion

Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
10 Doxorubicin Hydrochloride Injections

Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
11 Imatinib

The supply of Imatinib to NHS Scotland. The authority has awarded each product line as a ranked multi-supplier ranked framework agreement to seven (7) framework participants.
12 Etoposide Injection

Supply of Etoposide Injection to NHS Scotland. The authority has awarded award this lot as a ranked multi-supplier framework to three (3) framework participants.
13 Fluorouracil 25MG/ML Injection

Supply of Fluorouracil 25MG/ML Injections to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
14 Fluorouracil 50MG/ML Injection

Supply of Fluorouracil 50MG/ML Injections to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
15 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
16 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.
18 Idarubicin Hydrochlioride Injection Powder for Reconstitution

Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
19 Ifosfamide Injection Powder For Reconstitution

Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
20 Irinotecan Hydrochloride Injection

Supply of Irinotecan Hydrochloride Injection to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
21 Lanreotide Injection Prefilled Syringes

Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
22 Methotrexate Without Preservatives Injection

Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
23 Methotrexate Oral Solution

Supply of Methotrexate Oral Solution to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
25 Oxaliplatin Vial Solution

Supply of Oxaliplatin Vial Solution to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
26 Paclitaxel Concentrate For Intravenous Infusion

Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
27 Temozolomide Capsules

Supply of Temozolomide Capsules to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
28 Vincristine Without Preservatives Injection

Supply of Vincristine Without Preservatives Injection to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
29 Vinorelbine Injection

Supply of Vinorelbine Injections to NHS Scotland. The authority has awarded all presentations within this lot to a single supplier.
30 Octreotide Vials Long Acting (Excluding Homecare)

Supply of octreotide vials long acting(excluding homecare) to NHS Scotland. The authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) framework participants.
31 Octreotide Vials Long Acting (Including Homecare)

Supply of octreotide vials long acting(including homecare) to NHS Scotland. The authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) framework participants.
33 Pegfilgrastim 6 mg Pre-filled Syringe

Supply of pegfilgrastim 6mg pre-filled syringe to NHS Scotland. The authority has awarded this Lot as an unranked multi-supplier Framework to three (3) framework participants.
34 Aprepitant Capsules

Supply of aprepitant capsules to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single framework participant.
36 Topotecan Concentrate for Solution for Infusion

Supply of topotecan concentrate for solution for infusion to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single framework participant.
37 Octreotide Injection

Supply of Octreotide Injection. The authority has awarded all presentations within this lot to a single supplier.
38 Filgrastim Pre-Filled Syringe

Supply of Filgrastim Pre-Filled Syringe to NHS Scotland in a range of presentations. The authority has awarded all presentations within this lot to a single supplier.
39 All Other Oncology Generic Products/Presentations

Supply of all other products/presentations within this tender to NHS Scotland. Each product line was treated as an individual Lot, and has been awarded to a single supplier participant.

Award Detail

1 Waverley Pharma Europe (Ballsbridge)
  • Lot 2 Capecitabine Tablets
  • Num offers: 6
  • Value: £788,004
2 Consilient Health (Richmond)
  • Lot 3 Carboplatin Injection
  • Num offers: 3
  • Value: £501,334
3 Pfizer (Tadworth)
  • Lot 4 Cisplatin Injection
  • Num offers: 3
  • Value: £97,798
4 Accord Healthcare (North Harrow)
  • Lot 6 Cytarabine Injections
  • Num offers: 2
  • Value: £97,338
5 Medac Pharma (Stirling)
  • Lot 7 Dacarbazine Injections
  • Num offers: 1
  • Value: £236,452
6 Medac Pharma (Stirling)
  • Lot 8 Disodium Folinate Injection
  • Num offers: 1
  • Value: £342,260
7 Accord Healthcare (North Harrow)
  • Lot 9 Docetaxel Concentrate for Solution for Infusion
  • Num offers: 2
  • Value: £250,754
8 Medac Pharma (Stirling)
  • Lot 10 Doxorubicin Hydrochloride Injections
  • Num offers: 2
  • Value: £61,752
9 Accord Healthcare (North Harrow)
  • Lot 11 Imatinib
  • Num offers: 7
  • Value: £340,708 [share]
  • Awarded to group of suppliers.
10 Novartis Pharmaceuticals (Frimley)
  • Lot 11 Imatinib
  • Num offers: 7
  • Value: £340,708 [share]
  • Awarded to group of suppliers.
11 Teva (Castleford)
  • Lot 11 Imatinib
  • Num offers: 7
  • Value: £340,708 [share]
  • Awarded to group of suppliers.
12 Neon Healthcare (Ware)
  • Lot 11 Imatinib
  • Num offers: 7
  • Value: £340,708 [share]
  • Awarded to group of suppliers.
13 DR Reddys Laboratories (Beverley)
  • Lot 11 Imatinib
  • Num offers: 7
  • Value: £340,708 [share]
  • Awarded to group of suppliers.
14 Sandoz (Camberley)
  • Lot 11 Imatinib
  • Num offers: 7
  • Value: £340,708 [share]
  • Awarded to group of suppliers.
15 Zentiva Pharma (London)
  • Lot 11 Imatinib
  • Num offers: 7
  • Value: £340,708 [share]
  • Awarded to group of suppliers.
16 Accord Healthcare (North Harrow)
  • Lot 12 Etoposide Injection
  • Num offers: 3
  • Value: £172,585 [share]
  • Awarded to group of suppliers.
17 Fresenius Kabi (Runcorn)
  • Lot 12 Etoposide Injection
  • Num offers: 3
  • Value: £172,585 [share]
  • Awarded to group of suppliers.
18 Medac Pharma (Stirling)
  • Lot 12 Etoposide Injection
  • Num offers: 3
  • Value: £172,585 [share]
  • Awarded to group of suppliers.
19 Pfizer (Tadworth)
  • Lot 13 Fluorouracil 25MG/ML Injection
  • Num offers: 1
  • Value: £47,136
20 Medac Pharma (Stirling)
  • Lot 14 Fluorouracil 50 mg/ML Injection
  • Num offers: 2
  • Value: £256,048
21 Accord Healthcare (North Harrow)
  • Lot 1 Bendamustine Powder for Solution for Infusion
  • Num offers: 5
  • Value: £311,548
22 Pfizer (Tadworth)
  • Lot 15 Gemcitabine 38MG/ML Concentrate for Solution for Infusion Vials
  • Num offers: 2
  • Value: £27,066
23 Accord Healthcare (North Harrow)
  • Lot 16 Gemcitabine 100 mg/ml Concentrate for Solution for Infusion Vials
  • Num offers: 2
  • Value: £11,635
24 Pfizer (Tadworth)
  • Lot 18 Idarubicin Hydrochlioride Injection Powder for Reconstitution
  • Num offers: 1
  • Value: £99,636
25 Baxter Healthcare (Berkshire)
  • Lot 19 Ifosfamide Injection Powder For Reconstitution
  • Num offers: 2
  • Value: £1,836,044
26 Fresenius Kabi (Runcorn)
  • Lot 20 Irinotecan Hydrochloride Injection
  • Num offers: 6
  • Value: £211,502
27 Ipsen (Slough)
  • Lot 21 Lanreotide Injection Prefilled Syringes
  • Num offers: 1
  • Value: £5,329,440
28 Pfizer (Tadworth)
  • Lot 22 Methotrexate Without Preservatives Injection
  • Num offers: 2
  • Value: £301,276
29 Rosemont Pharmaceuticals (Leeds)
  • Lot 23 Methotrexate Oral Solution
  • Num offers: 1
  • Value: £122,640
30 Ranbaxy (London)
  • Lot 25 Oxaliplatin Vial Solution
  • Num offers: 3
  • Value: £135,558
31 Fresenius Kabi (Runcorn)
  • Lot 26 Paclitaxel Concentrate For Intravenous Infusion
  • Num offers: 3
  • Value: £235,290
32 Accord Healthcare (North Harrow)
  • Lot 27 Temozolomide Capsules
  • Num offers: 4
  • Value: £130,179
33 Teva (Castleford)
  • Lot 28 Vincristine Without Preservatives Injection
  • Num offers: 2
  • Value: £73,388
34 Medac Pharma (Stirling)
  • Lot 29 Vinorelbine Injection
  • Num offers: 1
  • Value: £53,200
35 Novartis Pharmaceuticals (Frimley)
  • Lot 30 Octreotide Vials Long Acting (Excluding Homecare)
  • Num offers: 2
  • Value: £3,258,010 [share]
  • Awarded to group of suppliers.
36 Teva (Castleford)
  • Lot 30 Octreotide Vials Long Acting (Excluding Homecare)
  • Num offers: 2
  • Value: £3,258,010 [share]
  • Awarded to group of suppliers.
37 Novartis Pharmaceuticals (Frimley)
  • Lot 31 Octreotide Vials Long Acting (Including Homecare)
  • Num offers: 2
  • Value: £50,148 [share]
  • Awarded to group of suppliers.
38 Teva (Castleford)
  • Lot 31 Octreotide Vials Long Acting (Including Homecare)
  • Num offers: 2
  • Value: £50,148 [share]
  • Awarded to group of suppliers.
39 Accord Healthcare (North Harrow)
  • Lot 33 Pegfilgrastim 6 mg Pre-Filled Syringe
  • Num offers: 3
  • Value: £242,580 [share]
  • Awarded to group of suppliers.
40 Sandoz (Camberley)
  • Lot 33 Pegfilgrastim 6 mg Pre-Filled Syringe
  • Num offers: 3
  • Value: £242,580 [share]
  • Awarded to group of suppliers.
41 Napp Pharmaceuticals (Cambridge)
  • Lot 33 Pegfilgrastim 6 mg Pre-Filled Syringe
  • Num offers: 3
  • Value: £242,580 [share]
  • Awarded to group of suppliers.
42 Zentiva Pharma (London)
  • Lot 34 Aprepitant Capsules
  • Num offers: 4
  • Value: £80,939
43 Accord Healthcare (North Harrow)
  • Lot 36 Topotecan Concentrate for Solution for Infusion
  • Num offers: 2
  • Value: £29,040
44 Ranbaxy (London)
  • Lot 37 Octreotide Injection
  • Num offers: 4
  • Value: £146,415
45 Accord Healthcare (North Harrow)
  • Lot 38 Filgrastim Pre-Filled Syringe
  • Num offers: 3
  • Value: £1,150,475
46 Accord Healthcare (North Harrow)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
47 Baxter Healthcare (Berkshire)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
48 Consilient Health (Richmond)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
49 DR Reddys Laboratories (Beverley)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
50 Drugsrus (Harrow)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
51 Fresenius Kabi (Runcorn)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
52 Glenmark Pharmaceuticals Europe (Watford)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
53 Hameln Pharmaceuticals (Gloucester)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
54 Ipsen (Slough)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
55 Kent Pharmaceuticals (Ashford)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
56 Martindale Pharma (Romford)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
57 Medac Pharma (Stirling)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
58 Morningside Pharmaceuticals (Leicestershire)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
59 Mylan (Hatfield)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
60 Pfizer (Tadworth)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
61 Ranbaxy (London)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
62 Rosemont Pharmaceuticals (Leeds)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
63 Sandoz (Camberley)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
64 Selective Supplies (Haywards Heath)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
65 Teva (Castleford)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
66 Tillomed Laboratories (Luton)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
67 Altan Pharma (None)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
68 Aspen Pharmacare (Maidenhead)
  • Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS
  • Num offers: 35
  • Value: £11,880,219 [share]
  • Awarded to group of suppliers.
69 Sandoz (Camberley)
  • Lot 5 Cyclophosphamide Injection, Powder for Reconstitution
  • Num offers: 2
  • Value: £173,904

Award Criteria

Logistics 5.0
PRICE 95.0

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price and quality.

Other Information

The estimated value referred to in sections II.I.7) and within each Lot covers the twenty-four (24) months contract duration and the full twenty-four (24) months extension options. (SC Ref:641897)

Reference

Domains